FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to endocrinology and cardiology and deals with treatment of metabolic syndrome. For this purpose complex treatment, which includes antihypertensive diet, individually selected aerobic physical exercise, introduction of metformin in dose 500 mg two days per day and melaxen, is carried out. Melaxen is introduced before going to bed 30 minutes before sleeping in dose 1-2 mg during first two weeks, and then in dose 3 mg during the following ten weeks. Course of treatment constitutes 12 weeks.
EFFECT: complex of non-pharmacological and pharmacological therapy as well as empirically selected mode of melaxen introduction ensure efficient treatment due to essential reduction of body weight and reduction of insulin-resistance in said group of patients.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING METABOLIC SYNDROME | 2015 |
|
RU2583944C1 |
| METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
| METHOD FOR TREATING PREDIABETES IN PERSONS WITH EXTERNAL EATING BEHAVIOR | 2022 |
|
RU2805361C1 |
| METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
| METHOD OF CORRECTING METABOLIC SYNDROME UNDER EXPERIMENTAL CONDITION | 2022 |
|
RU2806875C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
| METHOD OF TREATING BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES IN PATIENTS WITH METABOLIC SYNDROME | 2010 |
|
RU2438662C1 |
